| Bioactivity | GRK5-IN-2 (compound 707), a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. GRK5-IN-2 regulates the expression and/or release of insulin and is useful for the metabolic disease research[1]. | ||||||||||||
| Target | GRK5 | ||||||||||||
| Name | GRK5-IN-2 | ||||||||||||
| CAS | 1642839-27-7 | ||||||||||||
| Formula | C20H20N4O4 | ||||||||||||
| Molar Mass | 380.40 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Axel Ullrich (Prof. Dr.), et al. Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators. EP2818472A1. |
GRK5-IN-2
CAS: 1642839-27-7 F: C20H20N4O4 W: 380.40
GRK5-IN-2 (compound 707), a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.